scholarly journals Delay for First Consultation and Its Associated Factors among New Pulmonary Tuberculosis Patients of Central Nepal

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Wongsa Laohasiriwong ◽  
Roshan Kumar Mahato ◽  
Rajendra Koju ◽  
Kriangsak Vaeteewootacharn
Keyword(s):  
Pulmonary Tuberculosis ◽  
Associated Factors ◽  
Cross Sectional Study ◽  
Patient Delay ◽  
Cross Sectional ◽  
Tuberculosis Patients ◽  
Central Nepal ◽  
Delay Duration ◽  
Development Region ◽  
Public Health Challenge

Tuberculosis (TB) is still a major public health challenge in Nepal and worldwide. Most transmissions occur between the onset of symptoms and the consultation with formal health care centers. This study aimed to determine the duration of delay for the first consultation and its associated factors with unacceptable delay among the new sputum pulmonary tuberculosis cases in the central development region of Nepal. An analytical cross-sectional study was conducted in the central development region of Nepal between January and May 2015. New pulmonary sputum positive tuberculosis patients were interviewed by using a structured questionnaire and their medical records were reviewed. Among a total of 374 patients, the magnitude of patient delay was 53.21% (95% CI: 48.12–58.28%) with a median delay of 32 days and an interquartile range of 11–70 days. The factors associated with unacceptable patient delay (duration ≥ 30 days) were residence in the rural area (adj. OR = 3.10, 95% CI: 1.10–8.72;pvalue = 0.032) and DOTS center located more than 5 km away from their residences (adj. OR = 5.53, 95% CI: 2.18–13.99;pvalue < 0.001). Unemployed patients were more likely to have patient delay (adj. OR = 7.79, 95% CI: 1.64–37.00;pvalue = 0.010) when controlled for other variables.

scholarly journals Health seeking behaviour in pulmonary tuberculosis: a cross sectional study

2018 ◽  
Vol 5 (4) ◽  
pp. 1346 ◽  
Author(s):  
Jebamalar J. ◽  
Priya Senthilkumar ◽  
Mary Ramola
Keyword(s):  
Pulmonary Tuberculosis ◽  
Diagnostic Delay ◽  
Cross Sectional Study ◽  
Patient Delay ◽  
Diagnosis And Treatment ◽  
Sectional Study ◽  
Health Seeking Behaviour ◽  
Health Seeking ◽  
Cross Sectional ◽  
Tuberculosis Patients

Background: Health seeking behaviour has been identified as a complex and dynamic process which influences disease burden of tuberculosis. The present study aimed to study health seeking behaviour among pulmonary tuberculosis patients in a metropolitan city and to assess diagnostic and treatment delays and their determinants.Methods: A cross sectional study was conducted among newly diagnosed pulmonary tuberculosis patients registered for intensive phase of Category 1 ATT during the study period in Zone VIII of Chennai Corporation. The sample size was 197. The study was conducted over a period of one year from September 2015 to August 2016. A standardized WHO interview schedule on diagnostic delay was used for the study.Results: Patients sought healthcare for more severe symptoms like hemoptysis (delay of 38 days) earlier than for cough (delay o- 8 days). Other reasons for delay in seeking care were hope of self-resolution, financial constraints, fear of what the diagnosis would be, incompatible timings etcetera. The total mean delay from onset of symptoms till start of treatment was around 47 days, out of which the patient delay was 42 days. Factors significantly associated with delay included smoking, age more than 35 years and not approaching healthcare facilities first.Conclusions: An unacceptably high patient delay is the major contributor to total delay in the diagnosis and treatment of pulmonary tuberculosis patients. There is increased odds of delay among smokers compared to those who have never smoked. So smokers may be added to the high risk group for suspicion of tuberculosis for fast tracking of diagnosis and treatment. Furthermore, methods to curb over the counter medications should be explored.

scholarly journals Asymptomatic intestinal helminth co-infection among pulmonary tuberculosis patients in urban Surabaya: a preliminary study

2020 ◽  
Vol 3 (3) ◽  
pp. 112-118
Author(s):  
Rifat Nurwita Kusumaningtyas ◽  
Indah Setyawati Tantular ◽  
Deby Kusumaningrum ◽  
Rina K Kusumaratna
Keyword(s):  
Pulmonary Tuberculosis ◽  
Helminth Infection ◽  
Clinical Symptoms ◽  
Public Health Problem ◽  
Cross Sectional Study ◽  
Intestinal Helminth ◽  
Cross Sectional ◽  
Tuberculosis Patients ◽  
Preliminary Study ◽  
Few Data

BACKGROUNDPulmonary tuberculosis (TB) is a leading cause of morbidity and mortality, and East Java province is the second largest contributor of co-infection in Indonesia. Asymptomatic helminth infection among pulmonary tuberculosis patients causes another public health problem. Few data relate to helminth infection based on clinical and immunological outcomes of pulmonary TB in highly endemic areas. METHODSThis study was designed as a preliminary study and aimed to determine helminth co-infection among TB patients with a macroscopic assessment. This cross-sectional study was conducted in June-August 2017. RESULTSAmong 16 treated active TB patients from TB cohort data of Tanakali Kedinding health center found that 56% were stool smear-positive for Trichuris trichiura eggs, but had no clinical symptoms. CONCLUSIONWhether or not the helminth infection may have an impact on the diagnosis and treatment of active TB remains to be further investigated. Co-infection could be inhibited by the host immune response and improve the prognosis of TB treatment.

scholarly journals Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy

2017 ◽  
Vol 1 (2) ◽  
pp. 3-10
Author(s):  
Farkhanda Noureen ◽  
Abdur Rehman ◽  
Asif Hanif
Keyword(s):  
Pulmonary Tuberculosis ◽  
Early Recognition ◽  
Cross Sectional Study ◽  
Common Side Effect ◽  
Real Problem ◽  
Cross Sectional ◽  
Tuberculosis Patients ◽  
Pulmonary Tb ◽  
Global Pandemic ◽  
Short Course Chemotherapy

Background: Tuberculosis is a global pandemic which affects millions of people every year. The treatment of tuberculosis consists of simultaneous use of several drugs for a prolonged period of time, therefore anti-tuberculosis treatment induced toxicity is a real problem. It is the most common side effect leading to interruption of therapy. Wide variations have been found in the reported incidence of hepatotoxicity during short-course chemotherapy. This study was conducted to determine the frequency of ATT induced hepatotoxicity in pulmonary TB patients.Methodology: This descriptive, cross-sectional study was conducted at Gulab Devi Chest Hospital Lahore from November 2015 to January 2016. Total 137 pulmonary TB patients were included in this study according to inclusion and exclusion criteria. Data of patients was collected by Questionnaire. Blood samples were taken and LFTs were done. Data was analyzed by using SPSS version 16.Results: Data of 137 patients was taken in the study. Out of which 60 (43.8%) were male and 77 (56.2%) were female. The mean age was 40.59±16.57. 45 (32.8%) patients out of 137, develop hepatotoxicity while 92 (67.2%) shows normal patterns of liver function. 22 (16.1%) patients out of 137 showed elevation of serum bilirubin levels.Conclusion: ATT induced hepatotoxicity is a frequent complication in Pulmonary Tuberculosis patients. So, all patients put on ATT must be followed up for at least the initial month. The patients and the treating physicians must be well-educated about the adverse effects of the ATT, its early recognition and management.

Sign in / Sign up

Export Citation Format

Share Document